[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR200200616T2 - Dökülebilir sıvı araçları - Google Patents

Dökülebilir sıvı araçları

Info

Publication number
TR200200616T2
TR200200616T2 TR2002/00616T TR200200616T TR200200616T2 TR 200200616 T2 TR200200616 T2 TR 200200616T2 TR 2002/00616 T TR2002/00616 T TR 2002/00616T TR 200200616 T TR200200616 T TR 200200616T TR 200200616 T2 TR200200616 T2 TR 200200616T2
Authority
TR
Turkey
Prior art keywords
pourable liquid
compositions
liquid vehicles
tools
substances
Prior art date
Application number
TR2002/00616T
Other languages
English (en)
Inventor
Joseph Dobrozsi Douglas
William Hayes Ii Jerry
Olof Lindman Bjorn
Hristova Ivanova Rouja
Alexandridis Paschalis
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR200200616T2 publication Critical patent/TR200200616T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
  • Polyethers (AREA)

Abstract

Mevcut bulus bilesimler, malzemeler ve maddelerle birlestirilebilen dökülebilir sivi araçlariyla ilgilidir. Bu tip dökülebilir sivi araçlarin yararlarindan birisi, bilesimlerin, malzemelerin ve maddelerin nemli bir yüzeye etki etmelerini saglamaya yetecek bir süreyle, akma veya asinmaya direnç göstererek bilesimlerin bahsedilen yüzey üzerinde kalmalaridir. Bu tip dökülebilir sivi araçlar nesnelerin ve ayni zamanda canlilar dahil biyolojik veya canli organizmalarin yüzeylerinin temizlenmesi ve tedavi edilmesi dahil, fakat bunlarla kisitli degil, çesitli kullanimlara sahiptir.
TR2002/00616T 1999-09-11 2000-09-11 Dökülebilir sıvı araçları TR200200616T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15326099P 1999-09-11 1999-09-11

Publications (1)

Publication Number Publication Date
TR200200616T2 true TR200200616T2 (tr) 2002-06-21

Family

ID=22546438

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00616T TR200200616T2 (tr) 1999-09-11 2000-09-11 Dökülebilir sıvı araçları

Country Status (12)

Country Link
US (1) US6503955B1 (tr)
EP (1) EP1212091B1 (tr)
JP (1) JP2003509350A (tr)
CN (1) CN1373674A (tr)
AT (1) ATE355082T1 (tr)
AU (1) AU770516B2 (tr)
CA (1) CA2383570C (tr)
DE (1) DE60033671T2 (tr)
ES (1) ES2282134T3 (tr)
MX (1) MXPA02002607A (tr)
TR (1) TR200200616T2 (tr)
WO (1) WO2001019329A2 (tr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226138B1 (en) * 1999-10-08 2004-12-29 Affinium Pharmaceuticals, Inc. Fab i inhibitors
ES2240492T3 (es) * 2000-08-25 2005-10-16 Kowa Company, Ltd. Soluciones de ibuprofeno para rellenar capsulas y preparaciones de capsulas.
DK1343492T3 (da) * 2000-11-22 2006-03-06 Rxkinetix Inc Behandling af mucositis
US7049310B2 (en) * 2001-04-06 2006-05-23 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
US20060140985A1 (en) * 2003-01-10 2006-06-29 Zhong Zhang Lansoprazole formulations and related processes and methods
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
JP2006008696A (ja) * 2003-03-20 2006-01-12 Mitsubishi Pharma Corp アルギニンアミド類を含有する医薬製剤
ATE432484T1 (de) * 2003-04-03 2009-06-15 Seed Co Ltd Kontaktlinsen mit der fähigkeit einer andauernden medikamentenfreigabe und schutzlösungen dafür
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
AU2004305539B2 (en) * 2003-12-11 2010-09-02 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics
CA2635603C (en) * 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
US20070196329A1 (en) * 2006-01-20 2007-08-23 Erning Xia Disinfection efficacy of lens care regimen for rigid gas permeable contact lenses
BRPI0708773B1 (pt) * 2006-03-10 2021-10-19 Laboswiss Ag Método para solubilização, dispersão e estabilização de substâncias, produtos manufaturados de acordo com o método, bem como uso dos mesmos
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
CA2829241A1 (en) 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
ITFI20110241A1 (it) * 2011-11-03 2013-05-04 Lo Li Pharma Srl Formulazioni per migliorare la probabilità di fecondazione ed il numero di gravidanze
EP2861608B8 (en) 2012-06-19 2019-06-19 Debiopharm International SA Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
UY36570A (es) * 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
MY189221A (en) 2016-02-26 2022-01-31 Debiopharm Int Sa Medicament for treatment of diabetic foot infections
ES2881482T3 (es) 2017-02-01 2021-11-29 Johnson & Johnson Consumer Inc Una pastilla

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4100271A (en) 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4511563A (en) 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
EP0211601A3 (en) 1985-07-30 1988-01-13 International Minerals And Chemical Corporation Stabilization of growth promoting hormones
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US5030448A (en) 1986-05-15 1991-07-09 Emory University Method of delivering drugs to damaged or diseased tissue
US4810503A (en) 1987-03-31 1989-03-07 Basf Corporation Polymers which form gels at low concentrations in water
US4911926A (en) 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5135751A (en) 1988-11-16 1992-08-04 Mediventures Incorporated Composition for reducing postsurgical adhesions
US5681576A (en) * 1988-11-16 1997-10-28 Mdv Technologies, Inc. Method and composition for post surgical adhesion reduction
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5292516A (en) 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
US5306501A (en) 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5298260A (en) 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5071644A (en) 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5143731A (en) 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
CN1106259A (zh) 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
AU1332997A (en) 1995-12-11 1997-07-03 Mdv Technologies, Inc. Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers

Also Published As

Publication number Publication date
CA2383570A1 (en) 2001-03-22
MXPA02002607A (es) 2002-07-30
EP1212091A2 (en) 2002-06-12
ATE355082T1 (de) 2006-03-15
AU7128200A (en) 2001-04-17
DE60033671D1 (de) 2007-04-12
WO2001019329A2 (en) 2001-03-22
CA2383570C (en) 2008-08-12
ES2282134T3 (es) 2007-10-16
JP2003509350A (ja) 2003-03-11
US6503955B1 (en) 2003-01-07
WO2001019329A3 (en) 2001-08-02
DE60033671T2 (de) 2007-12-06
CN1373674A (zh) 2002-10-09
EP1212091B1 (en) 2007-02-28
AU770516B2 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
TR200200616T2 (tr) Dökülebilir sıvı araçları
HU9303537D0 (en) Water disperable organic polysiloxane composition
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
DE69934229D1 (de) Zusammensetzung zur entschichtung von photolack und organischen materialien von substratoberflächen
WO1998007809A3 (en) HARD SURFACE CLEANERS COMPRISING β-KETOESTER PRO-FRAGRANCES
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
ATE308880T1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
ID21200A (id) Komposisi dan metode untuk menghambat pertumbuhan mikroorganisme yang mengandung isotiazolon dan natrium hipobromit yang distabilisasi
BR9401459A (pt) Composição líquida de limpeza, e, processo para tratar materiais sujos com manchas para soltar ou remover as mesmas
DE50015780D1 (de) Reinigungsmittel für glaskeramische oberflächen
BR9801705B1 (pt) composiÇço de liberaÇço controlada e processo para controlar ou inibir o crescimento de fungos, bactÉrias, algas, organismos que provocam sujeira marinha, plantas e isentos.
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE326518T1 (de) Oberflächenreiniger
AR002253A1 (es) Compuesto derivado de fenil-alcanol biocida composición que lo contiene y procesos para producirlo
NO982360D0 (no) Sammensetning for behandling av flekker pÕ skittent°y, samt fremgangsmÕter ved behandling
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
DE60038802D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Oberflächen
BR9813049A (pt) Composições sinergéticas compreendendo uma oxatiazina e um benzotiofeno-2-carboxamida-s,s-dióxido
DE69111768D1 (de) Enzymatische Zusammensetzung zur Bestimmung von Äthanol.
AU5634099A (en) Composition for the removal of biological and organic substances
TR199900424A2 (tr) Yüzey temizleme aleti.
AR017402A1 (es) Una composicion blanqueadora para eliminar manchas de sustratos, un metodo para blanquear un sustrato manchado y un metodo para inhibir el desarrollomicrobiano en sustratos de superficie flexible o dura
MY121644A (en) Halopropargyl inclusion complexes
BR9915805A (pt) Composição conservante, métodos de tratamento de um substrato de madeira ou outro material e de conservação de madeira ou outro material, e, uso de um composto de amÈnio quaternário ou um triazol
WO2004096121A3 (en) Compositions and methods for preventing infection